Pharmaceutical Approval Update.
Pharmaceutical Approval Update.
P T. 2019 Mar;44(3):108-144
Authors: Kaufman MB
Abstract
Inbrija (levodopa inhalation powder) for oral inhalation for the treatment of "off" episodes in Parkinson's disease; Ultomiris (ravulizumab) injection for treating adults with paroxysmal nocturnal hemoglobinuria; and Yupelri (revefenacin) inhalation solution for the maintenance treatment of patients with COPD.
PMID: 30828229 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research